Dehorning Of Rhinos Can Help Save Them From Poachers, Suggests Study
Quick Read
Summary is AI generated, newsroom reviewed.
A study suggests dehorning rhinos can help reduce poaching amid population declines.
Cutting off horns significantly lowers poaching incentives for hunters, according to the study.
Between 2017 and 2023, poachers killed 1,985 rhinos despite $74 million spent on anti-poaching efforts.
A new study suggested that the dehorning of rhinoceroses can help save them as their populations continue to decline due to huge demand in markets, mostly illegal, for their horns. The study, published in the journal Science, noted that cutting the horns off rhinos leads to a significant reduction in poaching as it removes the incentive for the hunters.
Rhino poaching for horns is a serious issue. The horns of rhinos are said to have medicinal properties in some countries, although there's no scientific evidence. Poaching has led to a significant decline in rhino populations, and conservation efforts are underway to protect them.
The conservationist said in the study that they documented the poaching of 1985 rhinos between 2017-2023 across 11 southern African reserves despite around $74 million spent on antipoaching techniques, including focusing on law enforcement, tracking dogs, access controls and detection cameras.
The study noted that black and white rhino populations in the Greater Kruger (Kruger National Park and surrounding reserves) in South Africa declined from over 10,000 rhinos in 2010 to around 2,600 in 2023.
Meanwhile, the dehorning of 2284 rhinos across eight reserves led to around 78% reductions in poaching using 1.2% of the budget.
"Dehorning rhinos to reduce incentives for poaching was found to achieve a 78% reduction in poaching using just 1.2% of the overall rhino protection budget," said Dr Tim Kuiper of Nelson Mandela University, a lead author of the study.
"We might need to rethink our goals. Do we just want to arrest poachers? It doesn't appear to be making a massive difference to reducing rhino poaching," Dr Kuiper added.
Does dehorning affect rhinos?
The workers sedate the rhinos to cut off their horns using a power saw. They also apply a blindfold and earplugs to limit sensory overload. Dehorning does not hurt the animals and poses a very low risk. The horn gradually regrows.
"The headline result is that dehorning stood out for its effectiveness. We are cautious to say that the other interventions are not working. They worked when measured by whether they were detecting poachers. But detecting and arresting a load of poachers doesn't necessarily bend the curve on rhino poaching," Kuiper said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
5 hours ago
- Time of India
KU preferred institution among foreign students
T'puram: The University of Kerala is fast establishing itself as a leading international education destination, experiencing significant growth in foreign student enrolments over four years. For the 2025-26 academic year, the institution received 2,620 applications from 81 nations, marking a substantial increase from 1,100 students in 2021-22. According to Prof Sabu Joseph, director of the Centre for Global Academics (CGA), the university maintains its position as Kerala's foremost institution for international student intake. "The numbers demonstrate consistent growth 1,100 students from 35 countries in 2021-22, increasing to 1,400 in 2022-23, 1,600 in 2023-24 and 2,600 in 2024-25 from 64 countries. The 2025-26 academic year saw 2,620 applications from 81 countries, all submitted to the Indian Council for Cultural Relations (ICCR) portal for selection," he said. The current application distribution includes 1,265 for undergraduate programmes, 1,020 for postgraduate courses, and 335 for PhD studies. African nations constitute the largest applicant group, with sizeable applications from Iran, Iraq, Oman, Saudi Arabia, Sri Lanka, Nepal, Bangladesh, Philippines, Bhutan, Turkmenistan, Tajikistan, Indonesia, Malaysia, Jordan, Thailand, Vietnam, South Africa, Russia, France, and the USA. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Over 40 and Struggling With Belly Fat? Try 1 Teaspoon Daily (See What Happens A Week Later) Health Benefits Undo Popular course selections focus on commerce and management studies, with strong interest in political science, psychology, economics, education, linguistics and English literature. Scientific disciplines, including computer science, biotechnology, chemistry, environmental sciences, mathematics, physics and statistics also attract applicants. The university currently hosts 205 international students from 52 countries, including Colombia, Peru, UK, and the USA, through ICCR scholarships and self-financing options. Support services include orientation programmes, cultural events, and annual graduation ceremonies, creating an inclusive academic environment. "The university's NAAC A++ accreditation, strong NIRF rankings, efficient admission procedures, and advanced research facilities have established its position as a preferred international education hub. This sustained growth reflects its increasing global influence and dedication to academic excellence and multicultural education," said Sabu Joseph, adding that the KU continues to strengthen its position as an educational leader.
Time of India
18 hours ago
- Time of India
Paris climate target ‘will never die', remains world's ultimate goal: Researchers
BATHINDA: The world's expected passing of the Paris Agreement's 1.5°C limit during this decade raises pressure for countries to submit bold emissions reduction plans before COP30 in November, two researchers have warned. Prof Joeri Rogelj and Lavanya Rajamani, in a paper published in Science, argues that determining precisely when the world crosses 1.5°C is not necessary, because the decisions needed in response – reduce emissions rapidly in the near term – are already clear and do not suddenly change at that point. Instead, getting closer to 1.5°C should be a wake-up call for the world to focus on reducing greenhouse gas emissions this decade to limit the amount of warming the world experiences past 1.5°C to protect vulnerable groups, they say adding in the longer term reversing warming and getting below 1.5°C must be the goal. The paper follows the hottest year ever on record, commentary that the 1.5°C target is 'deader than a doornail' and the fact that only 21 out of 195 countries that signed the Paris Agreement have thus far submitted new five-year emissions reduction plans. Warming above 1.5°C greatly increases climate risks, including dangerous sea level rise, the collapse of coral reefs, the loss of the Greenland ice sheet and the dieback of the Amazon rainforest. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Ductless Air Conditioners Are Selling Like Crazy [See Why] Keep Cool Click Here Undo Key arguments in the paper includes: Approaching or exceeding 1.5°C of warming does not extinguish the Paris Agreement's ambitious goal but makes urgent climate action even more important. The exact timing of when the world crosses 1.5°C is less important than sustained efforts to cut emissions. The Paris Agreement remains vital as a global framework to guide emissions cuts and adaptation efforts, despite geopolitical challenges. Professor Rogelj, Director of Research at the Grantham Institute – Climate Change and the Environment, said: '1.5°C of warming is just around the corner and it will take a herculean effort to avoid it. 'This is deeply concerning, but crossing it makes the target more important because every fraction of warming – whether it is 1.6, 2 or 3°C – creates a more dangerous world and the longer we stay above 1.5°C, the higher the losses and damages for people will be. 'The key message of our paper is that 1.5°C will never die. It will remain our ultimate goal for a safe, livable and just planet. We need to remember that reversing warming is not a new goal, but already a key aim of the Paris Agreement.' The 2015 Paris Agreement aims to keep warming 'well below 2°C' and to pursue efforts to limit it to 1.5°C. Small island states proposed the 1.5°C target in the late 2000s as a matter of survival – '1.5 to stay alive' – and since 2015, it has become the immediate goal in the fight to tackle climate change. However, the world is not currently on track to keeping warming below the Paris Agreement targets. Most countries are still burning large amounts of fossil fuels, which release emissions that cause the climate to warm. Global warming is expected to exceed 1.5°C before the end of the decade, near 2°C by 2050, and rise to between 2.6°C and 3.1°C over the course of the century. These projections have resulted in commentary that 1.5°C is 'dead' and calls from some researchers to determine the precise timing of when 1.5°C is crossed. Professors Rogelj and Rajamani argue that exceeding 1.5°C does not mean abandoning the goal or triggering a specific policy shift for emissions reductions or adaptation needs but working harder to limit overshoot – the amount of warming experienced above 1.5°C . Their paper emphasises the need for countries to act with the highest ambition possible to bring emissions down to zero, achieve net-negative emissions, and get warming back below 1.5°C in the long-term. They note that even in a world that has crossed 1.5°C, countries and businesses can continue to follow emission pathways aligned with the target. The Paris Agreement remains the most important international tool for tackling climate change, particularly due to its requirement that countries submit plans to cut emissions every five years, the researchers say. While the deadline has been extended until September, just 21 of 195 countries signed up to the Paris Agreement have submitted their plan, known as a Nationally Determined Contribution or NDC. NDCs with the highest possible cuts to emissions will reduce the amount of time the world spends above 1.5°C and reduce harm to human life and ecosystems, the researchers say. Professor Lavanya Rajamani, Faculty of Law, University of Oxford, said: 'We want to reframe the way people talk about 1.5°C. Approaching or even surpassing it is a warning signal that states need to redouble their efforts, not to throw up their hands and declare 1.5°C 'over' or 'dead.' 'We need to stay focused on keeping warming below 1.5°C in the long term, and avoiding the worst impacts of climate change for people and the planet.' 'Our position is supported by a growing body of scientific evidence, the terms of the Paris Agreement, and the wider normative environment, including human rights obligations, that states are subject to.' Professor Rogelj, Director of Research at the Grantham Institute – Climate Change and the Environment, said: 'There is no such thing as a safe level of warming. 'Even below 1.5°C we see dangerous climate change. Devastating weather disasters in 2024 really made that clear – just think of the Valencia floods, Hajj heatwave and Hurricane Helene which collectively killed more than 1,500 people. 'Every tonne of carbon emitted and every fraction of a degree counts. That's why we need to see bold NDCs before the COP30 climate summit in November that deliver meaningful emissions reductions before the end of the decade. A focus on near-term reductions is key to limiting the harms that come with warming above 1.5°C.'
NDTV
2 days ago
- NDTV
Revolutionary New Drug Offers 99.9% Protection Against HIV
Despite decades of progress in HIV treatment, more than a million people are newly infected each year, and an effective vaccine remains out of reach. In a breakthrough, the US Food and Drug Administration has approved lenacapavir, a long-acting drug that offers near-complete protection against HIV with just two injections annually. While HIV prevention drugs, known as pre-exposure prophylaxis (PrEP), have existed for over a decade, their global impact has been limited due to the need for daily pill intake, a routine many struggle to follow consistently. "This is a historic day in the decades-long fight against HIV. Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic," said Daniel O'Day, Chairman and Chief Executive Officer of Gilead Sciences. "This is a medicine that only needs to be given twice a year and has shown remarkable outcomes in clinical studies, which means it could transform HIV prevention. Gilead scientists have made it their life's work to end HIV, and now, with the FDA approval of Yeztugo and in collaboration with our many partners, we can help to make that goal a reality." In 2024, Science hailed lenacapavir as its "Breakthrough of the Year". Lenacapavir, marketed under the brand name Yeztugo, has been shown to reduce the risk of HIV transmission by more than 99.9 percent in adults and adolescents making it functionally akin to a powerful vaccine. The company conducted two large clinical trials. The first, involving more than 2,000 women in sub-Saharan Africa, resulted in a 100 percent reduction in infections and demonstrated superiority over the daily oral pill Truvada. In the second trial, involving over 2,000 men and gender-diverse individuals, only two infections were recorded - a 99.9 percent prevention rate, again surpassing Truvada. Reported side effects included injection site reactions, headache, and nausea. Results from both trials were published in The New England Journal of Medicine, and the journal Science named lenacapavir its 2024 "Breakthrough of the Year." Pricing Raises Concerns Over Accessibility Despite the impressive results, optimism may be tempered by the drug's expected high cost. An earlier long-acting HIV prevention shot -- cabotegravir, which is injected every two months and was approved by the FDA in 2021 -- costs tens of thousands of dollars per year and has yet to make a major global impact. While Gilead hasn't disclosed a price for Yeztugo, analysts estimate the US launch cost could reach $25,000 per year. Lenacapavir's current list price for its previously approved use as a treatment for HIV is $39,000 annually, though that is expected to drop when used as a preventive. Activists are urging Gilead to drastically cut the price to help end the HIV pandemic. "Even high-income countries will not be able to afford widescale use of lenacapavir at prices above US $20,000 per year," said Andrew Hill of Liverpool University, who led a team of chemists and scientists that found it could be mass-produced and sold for as little as $25 per person per year. "To charge one thousand times more for a medicine with pandemic-ending potential would be abhorrent," added Winnie Byanyima, under-secretary-general of the United Nations. "We cannot end AIDS with medicines that are so costly." The approval also comes as President Donald Trump's administration has slashed funding for HIV treatment and prevention programs both abroad and within the United States.
